Effects of the rhizomes of Atractylodes japonica and atractylenolide i on allergic response and experimental atopic dermatitis

Archives of Pharmacal Research

Volumn 35, Issue 11, 2012, Pages 2007-2012

  Lim, Hyun ^a   Lee, Je Hyeong ^a   Kim, Jinwoong ^b   Kim, Yeong Shik ^b   Kim, Hyun Pyo ^a  

^a Kangwon National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

5 Lipoxygenase; Anti allergy; Atopic dermatitis; Atractylenolide I; Atractylodes japonica

Indexed keywords

ANTIALLERGIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ATRACTYLENOLIDE; ATRACTYLODES JAPONICA EXTRACT; CLOBETASOL PROPIONATE; EUDESMA 4,7 DIEN 8 ONE; HAPTEN; LEUKOTRIENE; PLANT EXTRACT; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; ATRACTYLODES JAPONICA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ISOLATION; IC 50; MALE; MAST CELL LEUKEMIA; MEDICINAL PLANT; MOUSE; NONHUMAN; RAT; RHIZOME;

EID: 84874408716     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-1118-3     Document Type: Article

References (32)

1. Chang, Y.-H.; Kim, C.; Jung, M.; Lim, Y.-H.; Lee, S.; and Kang, S.; Inhibition of melanogenesis by selina-4(14),7(11)-dien-8-one isolated from Atractylodis Rhizoma Alba. Biol. Pharm. Bull.; 30, 719-723 (2007).
2. Choi, K. H.; Jeong, S. I.; Lee, J. H.; Hwang, B. S.; Kim, S. J.; Lee, S.; Choi, B. K.; and Jung, K. Y.; Pharmacological mechanism responsible for the Atractylodes japonica-induced distal colonic contraction in rats. Phytomedicine, 18, 408-413 (2011a).
3. Choi, K. H.; Jeong, S. I.; Lee, J. H.; Hwang, B. S.; Lee, S.; Choi, B. K.; and Jung, K. Y.; Acetylene compound isolated from Atractylodes japonica stimulates the contractility of rat distal colon via inhibiting the nitrergic-purinergic relaxation. J. Ethnopharmacol.; 134, 104-110 (2011b).
4. Choi, O. H.; Kim, J. H.; and Kinet, J. P.; Calcium mobilization via sphingosine kinase in signaling by the FcÉRI antigen receptor. Nature, 380, 634-636 (1996).
5. Ding, H.-Y.; Wu, Y.-C.; and Lin, H.-C.; Phytochemical and pharmacological studies on Chinese changzhu. J. Chin. Chem. Soc.; 47, 561-566 (2000).
6. Dong, H.; He, L.; Huang, M.; and Dong, Y.; Anti-inflammatory compounds isolated from Atractylodes macrocephala Koidz. Nat. Prod. Res.; 22, 1418-1427 (2008).
7. Duan, J.; Wang, L.; Qian, S.; Su, S.; and Tang, Y.; A new cytotoxic prenylated dihydrobenzofuran derivative and other chemical constituents from the rhizomes of Atractylodes lancea DC. Arch. Pharm. Res.; 31, 965-969 (2008).
8. Han, S. B.; Lee, C. W.; Yoon, Y. D.; Lee, J. H.; Kang, J. S.; Lee, K. H.; Yoon, W. K.; Lee, K.; Park, S. K.; and Kim, H. M.; Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated from Achyranthes bidentata and Atractylodes japonica. Arch. Pharm. Res.; 28, 902-908 (2005).
9. Hong, M. H.; Kim, J.-H.; Bae, H.; Lee, N.-Y.; Shin, Y.-C.; Kim, S.-H.; and Ko, S.-G.; Atractylodes japonica Koidzumi inhibits the production of pro-inflammatory cytokines through inhibition of the NF-κB/IκB signal pathway in HMC-1 human mast cells. Arch. Pharm. Res.; 33, 843-851 (2010).
10. Jang, M. H.; Shin, M. C.; Kim, Y. J.; Kim, C. J.; Kim.; Y.; and Kim, E. H.; Atractylodes japonica suppresses lipopolysaccharide-stimulated expressions of inducible nitric oxide synthase and cyclooxygenase-2 in RAW 264.7 macrophages. Biol. Pharm. Bull.; 27, 324-327 (2004).
11. Jeong, S.-I.; Kim, S.-Y.; Kim, S.-J.; Hwang, B.-S.; Kwon, T.-H.; Yu, K.-Y.; Hang, S.-H.; Suzuki, K.; and Kim, K.-J.; Antibacterial activity of phytochemicals isolated from Atractylodes japonica against methicillin-resistant Staphylococcus aureus. Molecules, 15, 7395-7402 (2010).
12. Kang, T. H.; Han, N. R.; Kim, H. M.; and Jeong, H. J.; Blockade of IL-6 secretion pathway by the sesquiterpenoid atractylenolide III. J. Nat. Prod.; 74, 223-227 (2011).
13. Kitajima, J.; Kamoshita, A.; Ishikawa, T.; Takano, A.; Fukuda, T.; Isoda, S.; and Ida, Y.; Glycosides of Atractylodes japonica. Chem. Pharm. Bull.; 51, 152-157 (2003).
14. Leung, D. Y. M.; Hirsch, R. L.; Schneider, L.; Moody, C.; Takaoka R.; Li, S. H.; Meyerson, L. A.; Mariam, S. G.; Goldstein, G.; and Hanifin, J. M.; Thymopentin therapy reduces the clinical severity of atopic dermatitis. J. Allergy Clin. Immunol.; 85, 927-933 (1990).
15. Leung, D. Y. M.; Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol.; 96, 302-319 (1995).
16. Li, C. Q.; He, L. C.; Dong, H. Y.; and Jin, J. Q.; Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala Koidz. J. Ethnopharmacol.; 114, 212-217 (2007a).
17. Li, C. Q.; He, L. C.; and Jin, J. Q.; Atractylenolide I and atractylenolide III inhibit lipopolysaccharide-induced TNF-α and NO production in macrophages. Phytother. Res.; 21, 347-353 (2007b).
18. Marquardt, D. L. and Wasserman, S. I.; Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. J. Immunol.; 131, 934-939 (1983).
19. Matsuda, H.; Watanabe, N.; Geba, G. P.; Sperl, J.; Tsudzuki, M.; and Hiroi, J.; Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol.; 9, 461-468 (1997).
20. Mossman, T.; Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65, 55-63 (1983).
21. Murota, H. and Katayama, I.; Assessment of antihistamines in the treatment of skin allergies. Curr. Opin. Allergy Clin. Immunol.; 11, 428-437 (2011).
22. Novak, N.; New insights into the mechanism and management of allergic disease: atopic dermatitis. Allergy, 64, 265-275 (2009).
23. Oyoshi, M. K.; He, R.; Kumar, L.; Yoon, J.; and Geha, R. S.; Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol.; 102, 135-226 (2009).
24. Park, H. Y.; Lim, H.; Kim, H. P.; and Kwon, Y. S.; Downregulation of matrix metalloproteinase-13 by the root extract of Cyathula officinalis Kuan and its constituents in IL-1β-treated chondrocytes. Planta Med.; 77, 1528-1530 (2011).
25. Pu, S.; Pu, H.; Jin, D.; Qu, X.; Zhang, T.; Jiang, G.; Bai, Y.; and Jin, H.; Effect of n-butanol extract of Japanese atractylodes (Atractylodes japonica) on gastric ulcer in rats. Zhongcaoyao, 27, 410-413 (1996).
26. Rubin, P. and Mollison, K. W.; Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat.; 83, 188-197 (2007).
27. Rudikoff, D. and Lebwohl, M.; Atopic dermatitis. Lancet, 351, 1715-1721 (1998).
28. Schwartz, L. B.; Lewis, R. A.; Seldin, D.; and Austen, F.; Acid hydrolases and tryptase from secretory granules of disrupted human lining mast cells. J. Immunol.; 126, 1290-1294 (1981).
29. Suto, H.; Matsuda, H.; and Mitsuishi, K.; NC/Nga mice: a mouse model for atopic dermatitis. Int. Arch. Allergy Immunol.; 120, 70-75 (1999).
30. Suzuki, R.; Shimizu, T.; Kudo, T.; Yamashiro, Y.; and Oshida, K.; Effects of n-3 polyunsaturated fatty acids on dermatitis in NC/Nga mice. Prostaglandins Leukot. Essent. Fatty Acids, 66, 435-440 (2002).
31. Tries, S.; Neupert, W.; and Laufer, S.; The mechanism of action of the new anti-inflammatory compound ML3000: inhibition of 5-LOX and COX-1/2. Inflamm. Res.; 51, 135-143 (2002).
32. Yamamoto, K.; Yamashita, K.; Hitomi, N.; Suzuki, A.; and Yoneda, K.; Studies on the constituents of atractylodes rhizome, constituents in the rhizome of Atractylodes japonica and TLC analysis of Jutsu. Shoyakugaku Zasshi, 47, 12-16 (1993).